We want to share that APICES is an author and has received acknowledgment in the NALOPOOL study, which is a Real-World Data (RWD) study on opioid-induced constipation in cancer patients, published in Cancers. Moreover, APICES also contributed to…
Sustainability is no longer just a goal—it’s a responsibility. The clinical research industry plays a vital role in advancing healthcare and improving patient outcomes, bringing the latest and best treatments closer to patients to enhance their life expectancy…
We want to share the acknowledgment that APICES has received in PARASEC study, which is a prostate cancer retrospective study, published in the ASCO GU 2025 congress, in which APICES has collaborated in start-up, project management, monitoring, biostatistics,…
We want to share the acknowledgment that APICES has received in PRISMA-1 study, which is a phase II bladder cancer trial, published in the ASCO GU 2025 congress, in which APICES has collaborated in start-up, project management, and…
We want to share the acknowledgment that APICES has received in BLARWE study, which is a bladder cancer retrospective study, published in the ASCO GU 2025 congress, in which APICES has collaborated in start-up, project management, monitoring, biostatistics,…
We want to share the acknowledgment that APICES has received in a fertility retrospective study in the recent paper published in The Journal of Obstetrics and Gynaecology, in which APICES has collaborated in medical writing activities. This means a…
We want to share the acknowledgment that APICES has received in a rectal cancer phase II trial in the recent paper published in American Journal of Clinical Oncology, in which APICES has collaborated in data management, statistical analysis, and…
In the challenging clinical research world, some milestones celebrate dedication and commitment. This year, APICES, a leading company in the sector, proudly commemorates its 15th anniversary. Since its inception, APICES has been an internationally renowned CRO, recognized for…
The Spanish Agency for Medicines and Health Products (AEMPS) has expanded its accelerated evaluation process (fast-track), including bioequivalence studies. Interested sponsors must contact AEMPS before submitting the application to benefit from this process. This email should include the…
The Spanish Agency for Medicines and Health Products (AEMPS) has introduced an accelerated evaluation process (fast-track) to enhance Spain’s appeal for research on innovative medicines. This process will reduce the timelines for studies meeting the following criteria: Interested…
